RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
JOURNAL OF CLINICAL ONCOLOGY
Collezione ASL Biella

Items : 10

Intensive versus minimalist followup in patients treated for endometrial cancer: A multicentric randomized controlled trial (The TOTEM study-NCT00916708) in Journal of Clinical Oncology

2021
ASL Biella
ASL Cuneo 1
AOU Città della Salute di Torino

Zavallone L; Berretta R; Loda S; Ferrero A; Chiudinelli F; Comerci G; Fambrini M; Greggi S; Adorni M; Busato E; Marinaccio M; Menada MV; Mandato VD; Perrone AM; Di Cuonzo D; Peirano E; Fuso L; Piovano E; Ciccone G; Zola P;

Clinical outcomes of abiraterone acetate + prednisone (AA) + bone resorption inhibitors (BRI) versus AA alone as first-line therapy for castration-resistant prostate cancer (CRPC) with bone metastases (BM) in an international multicenter database in Journal of Clinical Oncology

2020
ASL Biella

Francini E; Montagnani F; Nuzzo PV; Gonzalez-Velez M; Alimohamed NS; Cigliola A; Moreno I; Rubio J; Crivelli F; Shaw G; Petrioli R; Bengala C; Francini G; Foncillas JG; Sweeney C; Higano CS; Bryce AH; Harshman LC; Lee-Ying R; Heng DYC;

Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: Retrospective analysis of clinical outcomes in Journal of Clinical Oncology

2020
AO Ordine Mauriziano
ASL Biella

Giannone G; Scotto G; De Giorgi U; Farolfi A; Katsaros D; Borella F; Ferrero A; Villa M; Tuninetti V; Ghisoni E; Turinetto M; Zavallone L; Aglietta M; Pasini B; Di Maio M; Valabrega G;

Early progression of disease (POD24) as survival predictor in MALT lymphoma in Journal of Clinical Oncology

2019
ASL Biella

Conconi A; Thieblemont C; Cascione L; Torri V; Kiesewetter B; Margiotta-Casaluci G; Gaidano G; Raderer M; Cavalli F; Lopez-Guillermo A; Johnson PWM; Zucca E;

2019
ASL Biella

Romano E; Poli R; Dumont C; Pietrogiovanna L; Vigan M; Servois V; Bidard F-C; Beaucaire-Danel S; Daniel C; Girard N; Hescot S; Savignoni A;

Efficacy of bone resorption inhibitors (BRI) + abiraterone acetate + prednisone (AA) vs. AA alone as first-line therapy for men with castration-resistant prostate cancer (CRPC) and bone metastases (BM) in an international multicenter hospital-based registry in Journal of Clinical Oncology

2019
ASL Biella

Francini E; Montagnani F; Vitale NP; Alimohamed NS; Candilejo IM; Rosellini P; Gonzalez-Velez M; Rubio J; Zhang L; Shaw G; Crivelli F; Petrioli R; Bengala C; Francini G; Foncillas JG; Bryce AH; Sweeney C; Harshman LC; Lee-Ying R; Heng DYC;

First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the Italian Research Group for Digestive Tract Cancer (GISCAD) CENTRAL (ColorEctalvastiNTRiAlLdh) and SENTRAL (Serum angiogenesis-cENTRAL) analysis in Journal of Clinical Oncology

2016
ASL Biella

Scartozzi M; Giampieri R; Daniele B; Ferrari D; Lonardi S; Zaniboni A; Cavanna L; Rosati G; Pella N; Zampino MG; Sozzi P; Casula L; Cozzi L; Germano D; Puzzoni M; Loretelli C; Zagonel V; Labianca R; Frontini L; Cascinu S;

Lactate dehydrogenase (LDH) levels to predict benefit from the continuation of bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Subgroup analysis of the randomized BEBYP study in Journal of Clinical Oncology

2016
ASL Biella

Marmorino F; Cremolini C; Loupakis F; Barbara C; Dargenio F; Miraglio E; Masi G; Salvatore L; Marcucci L; Antonuzzo L; Chiara S; Banzi C; Schirripa M; Amoroso D; Bonetti A; Martignetti A; Paris M; Boni L; Tomcikova D; Falcone A;

Italian observational study in patients with metastatic colorectal cancer (mCRC) treated with first-line cetuximab based regimen (ObservEr study) in Journal of Clinical Oncology

2014
ASL Biella

Di Fabio F; Rosati G; Lolli IR; Ruggeri EM; Ciuffreda L; Ferrari D; Tumolo S; Rosti G; Tralongo P; Ferrara R; Alabiso O; Chiara S; Ianniello GP; Di Costanzo F; Frassoldati A; Iacono C; Clerico M; Pavesi L; Bernardo G; Pinto C;

Aprepitant (AP) versus dexamethasone (D) for preventing delayed emesis induced by anthracyclines plus cyclophosphamide (A+C) chemotherapy (CT) in breast cancer patients (pts): A double-blind, multicenter, randomized study in Journal of Clinical Oncology

2013
ASL Biella
AOU Città della Salute di Torino

Roila F; Ballatori E; Fabi A; Fatigoni S; Chiara S; Ionta MT; Aieta M; Clerico M; Palladino MA; Indelli M; Garrone O; Bustreo S; Ruggeri B;